High Amount of PD-L1+Tumor Associated Macrophages Is Associated with Better Survival in Patients with Primary Testicular Lymphoma

被引：0
|
作者：
Pollari, Marjukka
Bruck, Oscar
Leivonen, Suvi-Katri
Pellinen, Teijo
Vahamurto, Pauli
Karjalainen-Lindsberg, Marja-Liisa
Mannisto, Susanna
Kellokumpu-Lehtinen, Pirkko-Liisa
Mustjoki, Satu
Leppa, Sirpa
机构：
来源：
BLOOD | 2017年 / 130卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2761
引用
收藏
页数：2
相关论文
共 50 条
  • [21] PD-L1 Expression Is Associated With VEGFA and LADC Patients' Survival
    Liu, Shaochuan
    Qin, Tingting
    Jia, Yanan
    Li, Kai
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [22] Reprogramming of PD-1+M2-like tumor-associated macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma
    Han, Zhen
    Wu, Xiwei
    Qin, Hanjun
    Yuan, Yate-Ching
    Schmolze, Daniel
    Su, Chingyu
    Zain, Jasmine
    Moyal, Lilach
    Hodak, Emmilia
    Sanchez, James F.
    Lee, Peter P.
    Feng, Mingye
    Rosen, Steven T.
    Querfeld, Christiane
    JCI INSIGHT, 2023, 8 (13)
  • [23] PD-L2 overexpression on tumor-associated macrophages is one of the predictors for better prognosis in lung adenocarcinoma
    Matsubara, Eri
    Shinchi, Yusuke
    Komohara, Yoshihiro
    Yano, Hiromu
    Pan, Cheng
    Fujiwara, Yukio
    Ikeda, Koei
    Suzuki, Makoto
    MEDICAL MOLECULAR MORPHOLOGY, 2023, 56 (04) : 250 - 256
  • [24] PD-L2 overexpression on tumor-associated macrophages is one of the predictors for better prognosis in lung adenocarcinoma
    Eri Matsubara
    Yusuke Shinchi
    Yoshihiro Komohara
    Hiromu Yano
    Cheng Pan
    Yukio Fujiwara
    Koei Ikeda
    Makoto Suzuki
    Medical Molecular Morphology, 2023, 56 : 250 - 256
  • [25] Quantitative spatial profiling of tumor associated macrophages and the PD-1/PD-L1 interaction in breast cancer
    Pelekanou, Vasiliki
    Neumeister, Veronique
    Pusztai, Lajos
    Rimm, David L.
    CANCER RESEARCH, 2018, 78 (04)
  • [26] Lymphoma Associated Macrophages Predict Survival in Uniformly Treated Patients with Classical Hodgkin Lymphoma
    Farinha, P.
    Rodrigues, S.
    Fernandes, T.
    Monteiro, A.
    da Silva, R. Lopes
    Salvador, J.
    Gerivaz, R.
    Costa, F.
    Ferreira, G.
    Lopes, C.
    Lacerda, T.
    Ferreira, J.
    Costa, I.
    de Sousa, A. Botelho
    MODERN PATHOLOGY, 2011, 24 : 296A - 296A
  • [27] Lymphoma Associated Macrophages Predict Survival in Uniformly Treated Patients with Classical Hodgkin Lymphoma
    Farinha, P.
    Rodrigues, S.
    Fernandes, T.
    Monteiro, A.
    Lopes da Silva, R.
    Salvador, J.
    Gerivaz, R.
    Costa, F.
    Ferreira, G.
    Lopes, C.
    Lacerda, T.
    Ferreira, J.
    Costa, I.
    Botelho de Sousa, A.
    LABORATORY INVESTIGATION, 2011, 91 : 296A - 296A
  • [28] Beyond T Cells: Understanding the Role of PD-1/PD-L1 in Tumor-Associated Macrophages
    Lu, Di
    Ni, Zhen
    Liu, Xiguang
    Feng, Siyang
    Dong, Xiaoying
    Shi, Xiaoshun
    Zhai, Jianxue
    Mai, Shijie
    Jiang, Jianjun
    Wang, Zhizhi
    Wu, Hua
    Cai, Kaican
    JOURNAL OF IMMUNOLOGY RESEARCH, 2019, 2019
  • [29] Roles of tumor-associated macrophages in anti-PD-1/PD-L1 immunotherapy for solid cancers
    Hao Zhang
    Lin Liu
    Jinbo Liu
    Pengyuan Dang
    Shengyun Hu
    Weitang Yuan
    Zhenqiang Sun
    Yang Liu
    Chengzeng Wang
    Molecular Cancer, 22
  • [30] Tumor-associated macrophages-additional effectors at anti-PD-1/PD-L1 therapy?
    Suda, Kenichi
    JOURNAL OF THORACIC DISEASE, 2017, 9 (11) : 4197 - 4200
12345